{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:24:20Z","timestamp":1787019860353,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T00:00:00Z","timestamp":1304640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T00:00:00Z","timestamp":1304640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Interleukin (IL)-6-type cytokines exert their effects through activation of the Janus kinase\/signal transducers and activators of transcription (JAK\/STAT) signaling cascade. The JAK\/STAT pathways play an important role in rheumatoid arthritis, since JAK inhibitors have exhibited dramatic effects on rheumatoid arthritis (RA) in clinical trials. In this study, we investigated the molecular effects of a small molecule JAK inhibitor, CP690,550 on the JAK\/STAT signaling pathways and examined the role of JAK kinases in rheumatoid synovitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fibroblast-like synoviocytes (FLS) were isolated from RA patients and stimulated with recombinant oncostatin M (OSM). The cellular supernatants were analyzed using cytokine protein chips. IL-6 mRNA and protein expression were analyzed by real-time PCR method and ELISA, respectively. Protein phosphorylation of rheumatoid synoviocytes was assessed by Western blot using phospho-specific antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>OSM was found to be a potent inducer of IL-6 in FLS. OSM stimulation elicited rapid phosphorylation of STATs suggesting activation of the JAK\/STAT pathway in FLS. CP690,550 pretreatment completely abrogated the OSM-induced production of IL-6, as well as OSM-induced JAK\/STAT, and activation of mitogen-activated kinases (MAPKs) in FLS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that IL-6-type cytokines contribute to rheumatoid synovitis through activation of the JAK\/STAT pathway in rheumatoid synoviocytes. Inhibition of these pro-inflammatory signaling pathways by CP690,550 could be important in the treatment of RA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/ar3333","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T14:29:23Z","timestamp":1304692163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["CP690,550 inhibits oncostatin M-induced JAK\/STAT signaling pathway in rheumatoid synoviocytes"],"prefix":"10.1186","volume":"13","author":[{"given":"Kiyoshi","family":"Migita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsumasa","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Torigoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumori","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Jiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiichiro","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Motokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,6]]},"reference":[{"key":"3099_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","volume":"358","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME: Rheumatoid arthritis. Lancet. 2001, 358: 903-911. 10.1016\/S0140-6736(01)06075-5.","journal-title":"Lancet"},{"key":"3099_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S1357-2725(03)00259-0","volume":"36","author":"SE Sweeney","year":"2004","unstructured":"Sweeney SE, Firestein GS: Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol. 2004, 36: 372-378. 10.1016\/S1357-2725(03)00259-0.","journal-title":"Int J Biochem Cell Biol"},{"key":"3099_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrrheum.2009.175","volume":"5","author":"Y Choi","year":"2009","unstructured":"Choi Y, Arron JR, Townsend MJ: Promising bone-related therapeutic targets for rheumatoid arthritis. Nat Rev Rheumatol. 2009, 5: 543-548. 10.1038\/nrrheum.2009.175.","journal-title":"Nat Rev Rheumatol"},{"key":"3099_CR4","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1002\/art.22161","volume":"54","author":"U Fearon","year":"2006","unstructured":"Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, FitzGerald O, Bresnihan B, Veale DJ: Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum. 2006, 54: 3152-3162. 10.1002\/art.22161.","journal-title":"Arthritis Rheum"},{"key":"3099_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/ard.56.3.184","volume":"56","author":"W Hui","year":"1997","unstructured":"Hui W, Bell M, Carroll G: Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis. 1997, 56: 184-187. 10.1136\/ard.56.3.184.","journal-title":"Ann Rheum Dis"},{"key":"3099_CR6","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/art.1780401207","volume":"40","author":"C Langdon","year":"1997","unstructured":"Langdon C, Leith J, Smith F, Richards CD: Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum. 1997, 40: 2139-2146. 10.1002\/art.1780401207.","journal-title":"Arthritis Rheum"},{"key":"3099_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3340297","volume":"334","author":"PC Heinrich","year":"1998","unstructured":"Heinrich PC, Behrmann I, M\u00fcller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway. Biochem J. 1998, 334: 297-314.","journal-title":"Biochem J"},{"key":"3099_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(02)00398-0","volume":"285","author":"T Kisseleva","year":"2002","unstructured":"Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW: Signaling through the JAK\/STAT pathway, recent advances and future challenges. Gene. 2002, 285: 1-24. 10.1016\/S0378-1119(02)00398-0.","journal-title":"Gene"},{"key":"3099_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.molmed.2004.09.007","volume":"10","author":"DC Borie","year":"2004","unstructured":"Borie DC, O'Shea JJ, Changelian PS: JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants. Trends Mol Med. 2004, 10: 532-541. 10.1016\/j.molmed.2004.09.007.","journal-title":"Trends Mol Med"},{"key":"3099_CR10","first-page":"491","volume":"10","author":"K West","year":"2009","unstructured":"West K: CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders. Curr Opin Investig Drugs. 2009, 10: 491-504.","journal-title":"Curr Opin Investig Drugs"},{"key":"3099_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1126\/science.1087061","volume":"302","author":"PS Changelian","year":"2003","unstructured":"Changelian PS, Flanagan ME, Ball DJ, Kent CR, Magnuson KS, Martin WH, Rizzuti BJ, Sawyer PS, Perry BD, Brissette WH, McCurdy SP, Kudlacz EM, Conklyn MJ, Elliott EA, Koslov ER, Fisher MB, Strelevitz TJ, Yoon K, Whipple DA, Sun J, Munchhof MJ, Doty JL, Casavant JM, Blumenkopf TA, Hines M, Brown MF, Lillie BM, Subramanyam C, Shang-Poa C, Milici AJ, et al: Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science. 2003, 302: 875-878. 10.1126\/science.1087061.","journal-title":"Science"},{"key":"3099_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/ard.2009.108159","volume":"69","author":"JH Coombs","year":"2010","unstructured":"Coombs JH, Bloom BJ, Breedveld FC, Fletcher MP, Gruben D, Kremer JM, Burgos-Vargas R, Wilkinson B, Zerbini CA, Zwillich SH: Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2010, 69: 413-416. 10.1136\/ard.2009.108159.","journal-title":"Ann Rheum Dis"},{"key":"3099_CR13","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/art.24567","volume":"60","author":"JM Kremer","year":"2009","unstructured":"Kremer JM, Bloom BJ, Breedveld FC, Coombs JH, Fletcher MP, Gruben D, Krishnaswami S, Burgos-Vargas R, Wilkinson B, Zerbini CA, Zwillich SH: The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo. Arthritis Rheum. 2009, 60: 1895-1905. 10.1002\/art.24567.","journal-title":"Arthritis Rheum"},{"key":"3099_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0002-9440(10)64634-2","volume":"157","author":"C Langdon","year":"2000","unstructured":"Langdon C, Kerr C, Hassen M, Hara T, Arsenault AL, Richards CD: Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol. 2000, 157: 1187-1196. 10.1016\/S0002-9440(10)64634-2.","journal-title":"Am J Pathol"},{"key":"3099_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"3099_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1182\/blood-2005-06-2413","volume":"107","author":"IS Lucet","year":"2006","unstructured":"Lucet IS, Fantino E, Styles M, Bamert R, Patel O, Broughton SE, Walter M, Burns CJ, Treutlein H, Wilks AF, Rossjohn J: The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor. Blood. 2006, 107: 176-183. 10.1182\/blood-2005-06-2413.","journal-title":"Blood"},{"key":"3099_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich PC, Behrmann I, Haan S, Hermanns HM, M\u00fcller-Newen G, Schaper F: Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003, 374: 1-20. 10.1042\/BJ20030407.","journal-title":"Biochem J"},{"key":"3099_CR18","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/ard.2005.050385","volume":"65","author":"JG Walker","year":"2006","unstructured":"Walker JG, Ahern MJ, Coleman M, Weedon H, Papangelis V, Beroukas D, Roberts-Thomson PJ, Smith MD: Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment. Ann Rheum Dis. 2006, 65: 1558-1564. 10.1136\/ard.2005.050385.","journal-title":"Ann Rheum Dis"},{"key":"3099_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrrheum.2009.175","volume":"5","author":"Y Choi","year":"2009","unstructured":"Choi Y, Arron JR, Townsend MJ: Promising bone-related therapeutic targets for rheumatoid arthritis. Nat Rev Rheumatol. 2009, 5: 543-548. 10.1038\/nrrheum.2009.175.","journal-title":"Nat Rev Rheumatol"},{"key":"3099_CR20","first-page":"1204","volume":"10","author":"F Atzeni","year":"2009","unstructured":"Atzeni F, Sarzi-Puttini P: Anti-cytokine antibodies for rheumatic diseases. Curr Opin Investig Drugs. 2009, 10: 1204-1211.","journal-title":"Curr Opin Investig Drugs"},{"key":"3099_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semcdb.2008.07.020","volume":"19","author":"AF Wilks","year":"2008","unstructured":"Wilks AF: The JAK kinases: not just another kinase drug discovery target. Semin Cell Dev Biol. 2008, 19: 319-328. 10.1016\/j.semcdb.2008.07.020.","journal-title":"Semin Cell Dev Biol"},{"key":"3099_CR22","first-page":"243","volume":"4","author":"JB Demoulin","year":"1998","unstructured":"Demoulin JB, Renauld JC: Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol Ther. 1998, 4: 243-256.","journal-title":"Cytokines Cell Mol Ther"},{"key":"3099_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1034\/j.1600-065X.2000.17812.x","volume":"178","author":"LD Notarangelo","year":"2000","unstructured":"Notarangelo LD, Giliani S, Mazza C, Mella P, Savoldi G, Rodriguez-P\u00e9rez C, Mazzolari E, Fiorini M, Duse M, Plebani A, Ugazio AG, Vihinen M, Candotti F, Schumacher RF: Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model. Immunol Rev. 2000, 178: 39-48. 10.1034\/j.1600-065X.2000.17812.x.","journal-title":"Immunol Rev"},{"key":"3099_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.0105-2896.2005.00220.x","volume":"203","author":"M Pesu","year":"2005","unstructured":"Pesu M, Candotti F, Husa M, Hofmann SR, Notarangelo LD, O'Shea JJ: Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs. Immunol Rev. 2005, 203: 127-142. 10.1111\/j.0105-2896.2005.00220.x.","journal-title":"Immunol Rev"},{"key":"3099_CR25","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1021\/jm801142b","volume":"51","author":"JK Jiang","year":"2008","unstructured":"Jiang JK, Ghoreschi K, Deflorian F, Chen Z, Perreira M, Pesu M, Smith J, Nguyen DT, Liu EH, Leister W, Costanzi S, O'Shea JJ, Thomas CJ: Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550). J Med Chem. 2008, 51: 8012-8018. 10.1021\/jm801142b.","journal-title":"J Med Chem"},{"key":"3099_CR26","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/art.27536","volume":"62","author":"TH Lin","year":"2010","unstructured":"Lin TH, Hegen M, Quadros E, Nickerson-Nutter CL, Appell KC, Cole AG, Shao Y, Tam S, Ohlmeyer M, Wang B, Goodwin DG, Kimble EF, Quintero J, Gao M, Symanowicz P, Wrocklage C, Lussier J, Schelling SH, Hewet AG, Xuan D, Krykbaev R, Togias J, Xu X, Harrison R, Mansour T, Collins M, Clark JD, Webb ML, Seidl KJ: Selective functional inhibition of JAK3 kinase is sufficient for efficacy in collagen induced arthritis in mice. Arthritis Rheum. 2010, 62: 2283-2293. 10.1002\/art.27536.","journal-title":"Arthritis Rheum"},{"key":"3099_CR27","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P","volume":"41","author":"N Takagi","year":"1998","unstructured":"Takagi N, Mihara M, Moriya Y, Nishimoto N, Yoshizaki K, Kishimoto T, Takeda Y, Ohsugi Y: Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum. 1998, 41: 2117-2121. 10.1002\/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P.","journal-title":"Arthritis Rheum"},{"key":"3099_CR28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.autrev.2009.01.012","volume":"8","author":"JE Fonseca","year":"2009","unstructured":"Fonseca JE, Santos MJ, Canh\u00e3o H, Choy E: Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev. 2009, 8: 538-542. 10.1016\/j.autrev.2009.01.012.","journal-title":"Autoimmun Rev"},{"key":"3099_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ncprheum0338","volume":"2","author":"N Nishimoto","year":"2006","unstructured":"Nishimoto N, Kishimoto T: Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol. 2006, 2: 619-626. 10.1038\/ncprheum0338.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3099_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/rheumatology\/kem297","volume":"47","author":"T Thalhamer","year":"2008","unstructured":"Thalhamer T, McGrath MA, Harnett MM: MAPKs and their relevance to arthritis and inflammation. Rheumatology. 2008, 47: 409-414.","journal-title":"Rheumatology"},{"key":"3099_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-5793(99)01717-2","volume":"465","author":"M Suzuki","year":"2000","unstructured":"Suzuki M, Tetsuka T, Yoshida S, Watanabe N, Kobayashi M, Matsui N, Okamoto T: The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett. 2000, 465: 23-27. 10.1016\/S0014-5793(99)01717-2.","journal-title":"FEBS Lett"},{"key":"3099_CR32","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1038\/sj.onc.1203925","volume":"19","author":"SG Rane","year":"2000","unstructured":"Rane SG, Reddy EP: Janus kinases: components of multiple signaling pathways. Oncogene. 2000, 19: 5662-5679. 10.1038\/sj.onc.1203925.","journal-title":"Oncogene"},{"key":"3099_CR33","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1084\/jem.181.4.1425","volume":"181","author":"T Musso","year":"1995","unstructured":"Musso T, Johnston JA, Linnekin D, Varesio L, Rowe TK, O'Shea JJ, McVicar DW: Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med. 1995, 181: 1425-1431. 10.1084\/jem.181.4.1425.","journal-title":"J Exp Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3333\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T07:04:10Z","timestamp":1728371050000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,6]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,6]]}},"alternative-id":["3099"],"URL":"https:\/\/doi.org\/10.1186\/ar3333","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,6]]},"assertion":[{"value":"1 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R72"}}